Microvascular Therapeutics (MVT) has entered into a licensing agreement with the University of North Carolina at Chapel Hill and Columbia University for the use of perfluorocarbon nanodroplets and ult
Tucson, Arizona, August 1st, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the Natio
Tucson, Arizona, July 22nd, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the Nation